27.07.2011 • NewsQ2 2011sales and profitsSigma-Aldrich

Sigma-Aldrich Q2 Profit Rises

Sigma-Aldrich Tuesday reported a better-than-expected rise in second-quarter profit, as demand for its specialty chemicals lifted revenues by 15% from the prior-year quarter. The company also reaffirmed its adjusted earnings outlook for the full year.

The St. Louis, Mo.-based company earned $113 million or $0.91 per share for the quarter, compared to $97 million or $0.79 per share last year.

Excluding items, adjusted earnings for the quarter were $115 million or $0.93 per share, compared to $99 million or $0.81 per share last year.

On average, 12 analysts polled by Thomson Reuters expected earnings of $0.92 per share for the quarter. Analysts' estimates typically exclude special items.

Quarterly sales rose 15% to $637 million from $554 million last year. Wall Street analysts expected revenues of $621.17 million.

On an organic basis, sales improved 6%. Among segments, Research business grew organically by 4%, led by the Asia Pacific-Latin America region. Sales for the Sigma-Aldrich Fine Chemicals business achieved organic growth of 10%, led by double-digit improvement in bioscience and high tech products.

Looking ahead to fiscal year 2011, the company reaffirmed its adjusted earnings outlook of $3.60 to $3.75 per share.

Street analysts currently expect earnings of $3.70 per share for the full year.

The company also reiterated that its organic sales growth is expected to be in the mid-single digit range for 2011.

 

Interview

Specialty Chemicals in a Shifting World
Adapting to Tariffs and Strengthening Regional Networks

Specialty Chemicals in a Shifting World

Jennifer Abril, President & CEO of SOCMA, discusses the impact of new tariffs and the importance of regional supply networks in the specialty chemical industry.

Free Virtual Event

Sustainability in Bioprocessing
Bioprocess Forum

Sustainability in Bioprocessing

Join us to explore hot topics in sustainable bioprocessing like the industrial potential of enzymatic synthesis, innovative biocatalysis techniques, and the use of digital twins in bioprocessing.